For example, while AS-NMD is used for the inhibition of RBM10 to RBM5, RBM5 also controls the expression of RBM10 splicing variants in turn through AS-NMD to reduce the action of cancer promotion [38, 39]. This evidence concerns the gene RBM10 and cancer.